| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Contributions |
From the Department of Medicine III, University of Cologne, Cologne, Germany.
Correspondence to Dirk J. Beuckelmann, MD, University of Cologne, Department of Medicine III, Joseph-Stelzmann-Str.9, D-50924 Cologne, Germany. E-mail Dirk.Beuckelmann{at}uni-koeln.de
| Abstract |
|---|
|
|
|---|
Key Words: action potential computer model arrhythmia heart failure
| Introduction |
|---|
|
|
|---|
A prominent feature of the single myocyte of the failing heart is an alteration of [Ca2+]i handling26,27 and an enhanced activity of the Na+-Ca2+ exchanger.28,29 It has been postulated that these abnormalities may give rise to arrhythmias in heart failure, but proof for this hypothesis remains lacking. Mathematical models of the cellular AP and its underlying ionic currents may help to elucidate possible arrhythmogenic mechanisms on a cellular level. For this purpose, a model of the ventricular AP based on Hodgkin-Huxley formalisms30 was developed. Selected depolarizing and repolarizing ionic currents and the [Ca2+]i handling incorporated into this model were based on quantitative measurements in single ventricular myocytes isolated from nonfailing and terminally failing human hearts.
Using this model, we evaluated which ionic currents may affect the AP in human myocardium and which cellular abnormalities in human ventricular myocytes from failing hearts may contribute to arrhythmogenesis in heart failure.
| Materials and Methods |
|---|
|
|
|---|
Voltage-clamp data for ICa, Ito, and IK1 and Ca2+ measurements are as described in our previous studies.13,16,19,20,27 Experiments were carried out at 37°C. (See References 13, 16, 19, 20, and 2713 16 19 20 27 for a detailed description of the experimental conditions.)
Under space-clamp conditions, the differential equation describing the time-dependent changes in membrane potential (V) is as follows:
![]() |
![]() |
The complete set of equations of all ionic currents, ionic exchanger
currents, and [Ca2+]i
handling is provided in the Appendix
.
Fast Na+ Current: INa
INa is calculated using equations of
the LR model.31 Sakakibara et
al25 have demonstrated that the characteristics
of INa in isolated human
ventricular myocytes are similar to those of other
mammalian species and that INa kinetics are
identical in several different disease states. Therefore, we use the
same equations for INa in both cell
groups.
L-Type Ca2+ Current: ICa
The kinetics of ICa have been shown
to be unaltered in myocytes from failing
hearts.15,16,18 Therefore, for calculating
ICa the same gating parameters
are used in both groups. In animal and human studies, it has been
clearly demonstrated that the inactivation of
ICa is voltage dependent. In addition,
there is experimental evidence indicating that inactivation of
ICa is also Ca2+
dependent.32,33 This type of regulation of
ICa seems also to exist in human
ventricular myocytes.17 Consequently,
we integrate a proportional factor, fCa, in the
equation of ICa that is formulated as
follows:
fCa=[1+([Ca2+]i/600
nmol/L)]-1. Fitting of experimental
ICa is performed with simulated
[Ca2+]i transients
formulated as follows: A ·
[exp(-t/
1)-exp(-t/
2)]+R.
A is a proportional factor,
1 and
2 are time constants, and R is the basal
Ca2+ level. By this approach, the important
Ca2+-dependent inactivation of
ICa may be sufficiently incorporated into
this model as the simulations of ICa
indicate.
Transient Outward K+ Current:
Ito
No significant alterations of the kinetics of
Ito have been found in failing compared
with control myocytes.14 Therefore, the same
gating parameters for simulating
Ito are used in both groups. On the basis
of experimental data,20 the current density of
Ito is assumed to be 64% of the value
measured in nonfailing myocytes. The steady-state activation and
inactivation curves of Ito obtained from
fitting the experimental voltage clamp traces are shown in Figure 1
.
|
Data are fitted by a Boltzmann distribution. The parameters
V0.5 and k of the Boltzmann equation
in the model are compared with those from experimental voltage-clamp
studies (Table 1
). The differences are
negligible and can be explained by the different solutions used in the
experiments to block interfering currents.
|
Delayed Rectifier K+ Current:
IK
The existence of two components of the delayed rectifier, a
rapidly activating component (IKr) and a
slowly activating component (IKs), has been
documented by Li et al.21 On the basis of their
data, both currents are incorporated into the model. The method for
simulating IKr in human
ventricular myocytes is the same as that used by
Sanguinetti and Jurkiewicz34 in guinea pig
myocytes. For simplification, the slow inactivation of
IKr during depolarization at +50 mV
observed experimentally (Li et al21) is not
considered. Quantitative values of IKs are
calculated by fitting the experimental voltage-clamp traces
recorded in the study of Li et al to a single exponential function.
On depolarization, the activation of IKs in
human ventricular myocytes follows a sigmoidal time course,
as has been reported in guinea pig ventricular
myocytes.34 This strong sigmoidal activation has
also been found in wild-type
IKs.35 Therefore, the
second power of activation in the Hodgkin-Huxley formalism of
IKs is used to obtain an adequate fit to
the measured traces. In animal studies, IKs
has been shown to be sensitive to intracellular
Ca2+ 36,37, and IKr
has been shown to be sensitive to extracellular
K+.37 In the only study
investigating IKs and
IKr in human ventricular
myocytes (ie, that of Li et al21), experiments
were performed only with 5.0 mmol/L EGTA in the pipette solution
and with one extracellular K+ concentration.
Thus, it is unclear whether this type of regulation found in animal
ventricular myocytes also exists in human
ventricular myocytes. Consequently, we do not consider such
a regulation of IKs and
IKr in our model. At the present time,
the properties of IKr and
IKs in heart failure are unknown.
Therefore, we assume that IKs and
IKr are unchanged in heart
failure.
Inward Rectifier K+ Current:
IK1
The simulated current density of IK1
is assumed to be reduced by 25% at -70 mV in the failing myocyte
compared with control myocytes on the basis of results of experimental
studies.13,22 Since the time-dependent
inactivation of IK1 can be observed only at
voltages negative to -110 mV,22
IK1 is assumed to be time independent. As
in animal ventricular myocytes,
IK1 is also almost solely carried by
K+ ions in human ventricular
myocytes.22 Therefore, the reversal potential of
IK1 is calculated by Nernst's
equation for K+.
Na+-Ca2+ Exchanger Current:
INaCa
INaCa is integrated into the model
using values from the LR model because data in human
ventricular myocytes are not available at present. To
compute INaCa in a nonfailing myocyte, only
kNaCa is changed to 50% of the value used
in the LR model, taking into account the smaller activity of
INaCa in human myocytes compared with
different animal species.38 With such a value of
kNaCa, INaCa
simulated in a nonfailing myocyte with a protocol similar to that in
experiments by Sham et al38 is in the range of
the experimental data (model, 0.50 pA/pF; experiment, 0.54±0.1 pA/pF).
In a failing myocyte, we assume 65% greater
INaCa than in a nonfailing myocyte. This
assumption is based on the observation of an increase of
Na+-Ca2+ exchanger activity in
myocardium from patients with heart
failure.28
Na+-K+ Pump Current:
INaK
For simulation of INaK, we use the
equation of the LR model. The magnitude of
INaK has been chosen in a way such that APD
in a nonfailing myocyte at a stimulation frequency of 1 Hz is in the
range measured experimentally in single human myocytes from nonfailing
heart by our group (unpublished data) and by Peeters et
al.39 There is a report suggesting that the
concentration of the
Na+,K+-ATPase is decreased
by 42% in failing hearts.40 This alteration is
assumed to represent a proportional decrease in
INaK. Therefore, a 42% reduction in
INaK of a failing myocyte is incorporated
into the model.
[Ca2+]i Transient
To simulate the
[Ca2+]i transients in
both groups, the approach of the LR model has been
chosen.31 In some equations for calculating the
Ca2+ homeostasis, the parameters are
changed in a way such that simulated
[Ca2+]i transients
closely resemble those measured in nonfailing and failing human
ventricular myocytes.27 The
differences in simulations of the intracellular
Ca2+ fluxes to the LR model are described below.
For more details, see Reference 3131 .
CICR by the SR
The threshold for CICR from the cardiac SR is reduced from 0.18
to 0.005 µmol/L because of the smaller size of the peak
ICa in human compared with animal myocytes.
The time constants for the activation and deactivation of the release
process is set to 4 ms. Experimental studies have revealed that the
function and number of the ryanodine channels are widely unaltered in
heart failure.41,42 Therefore, the CICR mechanism
is assumed to be equal in nonfailing and failing myocytes.
Ca2+ Buffers in the Myoplasm and the SR
There are reports that the affinity of troponin C to
Ca2+ is unaltered in heart
failure.43 Consequently, because of the great
contribution of troponin C to the total myoplasmic
Ca2+ buffer capacity, we have used equal
myoplasmic buffer concentrations in nonfailing and failing myocytes.
For simulating the Ca2+ buffering in the JSR
(calsequestrin), we adopted the values of the LR model for our model.
There is no evidence of differences in the level of calsequestrin in
heart failure.44 Therefore, equal concentrations
of calsequestrin have been used in both cell groups. With the approach
of Hilgemann and Noble,45 we compute the
steady-state buffering process numerically by using Newton's iterative
method.
Ca2+ Uptake and Leakage by the NSR
Reduction of the activity of Ca2+-ATPase
of the SR in heart failure, as shown in experimental
studies,46,47 is integrated into the model. To
obtain the characteristic Ca2+ transients in both
cell groups, the scaling factor for Ca2+ uptake,
up, is set to 0.0045
mmol/(L · ms) in a nonfailing and 0.0015 mmol/(L ·
ms) in failing myocytes. The Kleak value in both
cell groups was chosen in a way such that Ca2+
leakage out of the NSR is equal to the Ca2+
uptake in the NSR at basal
[Ca2+]i (nonfailing,
Kleak=0.00026 ms-1;
failing, Kleak=0.00017
ms-1).
Sarcolemmal Ca2+ Pump
The contribution of the sarcolemmal Ca2+
pump to the extrusion of Ca2+ out of the cell has
been shown to be very small.48 Therefore, we do
not consider this pump in our model.
Background Currents
A linear Ca2+ background current,
ICa,b, is incorporated into the model for
balancing the Ca2+ extrusion through
INaCa at resting potential in both cell
groups. By this mechanism, the resting level of
[Ca2+]i is maintained at
0.12 µmol/L in a nonfailing myocyte and at 0.15 µmol/L in
a failing myocyte.
A linear Na+ background current, INa,b, is also incorporated into the model of a nonfailing myocyte for maintaining the resting level of [Na+]i (10 mmol/L in both cell groups). In a failing myocyte, Na+ ion extrusion by INaK balances the Na+ ion entry by INaCa so that incorporation of INa,b into this model is not necessary in that cell.
The model is written in Pascal and tested using a Turbo-Pascal compiler (Borland International) on an IBM-compatible computer with an Intel Pentium central processing unit. A fourth-order Runge-Kutta method with fixed time intervals is used for numerical integration of differential equations.
For the simulations in the present study, the fixed time interval for voltage-clamp simulations is 0.01 to 0.1 ms. The time interval for AP simulations is held at 0.0001 ms during the stimulus current and then set at 0.01 to 0.1 ms. APs are elicited in all simulations with 10 pA/pF of Ist for 0.7 ms. Standard software is used to convert the simulated data in ASCII format and to prepare the figures. Fitting of the voltage-clamp traces is performed with a commercial software using a nonlinear least-squares algorithm.
| Results |
|---|
|
|
|---|
|
|
|
Figure 4
shows
Ito simulated in a failing myocyte. The
corresponding experimental traces are depicted in Figure 4B
. The pulse
protocol is shown as an inset. The current density of
Ito at +40 mV (difference between peak
current and maintained current at the end of the pulse) was 8.9 pA/pF.
The time course of inactivation of Ito was
largely independent of voltage. The time constant of its
monoexponential decay in the voltage range of +10 to
+80 mV was 13±0.9 ms. These values of Ito
are in accordance with experimental data measured at
37°C.20 Figures 2
, 3
, and 4
demonstrate that
simulated ICa,
[Ca2+]i transients, and
Ito resemble the experimental
recordings closely with regard to their magnitude and
kinetics.
|
The simulations of voltage-clamp experiments of
IKr and IKs are
depicted in Figure 5
. Depolarizations
from a holding potential of -60 mV to the various clamp pulse
potentials generate a rapidly activating (Figure 5A
) and a slowly
activating (Figure 5B
) K+ current through delayed
rectifier channels with close approximation to experimental
data.21 To validate simulations of
IKr and IKs,
current-voltage relations for IKtail of
IKr and IKs are
shown in Figure 5C
. The values are very close to experimental
data.21 Activation voltage dependence was determined by
normalizing IKtail at each test potential
in Figure 5C
to the current at the most positive potential. Results are
shown in Figure 5D
. Curves are fitted to a Boltzmann distribution
function. V0.5 and k values are
consistent with experimental results (Table 3
).
|
|
Data of IK1 are shown in Figure 6
. Experimental traces of
IK1 in failing myocytes are depicted in
Figure 6A
. Currents were elicited from a holding potential of -30 mV
to the indicated voltages. On the basis of these experimental data,
IK1 was simulated using the same pulse
protocol. The current-voltage relations of simulated
IK1 in a nonfailing and a failing myocyte
are shown in Figure 6B
. The whole-cell current slope conductance at the
reversal potential of IK1 in a failing
myocyte is smaller (0.23 nS/pF) than that in a nonfailing myocyte (0.4
nS/pF). In addition, the current density of
IK1 at -70 mV (0.6 pA/pF [failing
myocyte] versus 0.8 pA/pF [nonfailing myocyte]) and at -100 mV
(-10 pA/pF [failing myocyte] versus -15 pA/pF [nonfailing
myocyte]) is assumed to be smaller in a failing than in a nonfailing
myocyte.
|
Simulated AP Is Prolonged in Heart Failure
After showing that simulated ionic currents and
[Ca2+]i transients
resemble experimental measurements, APs of a nonfailing and of a
failing myocyte were simulated. To obtain a steady state in
[Ca2+]i transients, 10
APs were elicited at a frequency of 1 Hz. Under these conditions, both
APs are distinctly different (Figure 7
, top; nonfailing, dashed line; failing, solid line).
|
APD90 was significantly longer in a failing than
in a nonfailing myocyte (548.8 versus 374.0 ms, respectively). In
contrast to this, differences in APD25 and
APD50 between both cell groups were smaller
(APD25: nonfailing, 262.9 ms; failing, 305.7 ms;
APD50: nonfailing, 310.2 ms; failing, 374.5 ms).
Therefore, the prolongation of APD in heart failure was mainly due to
the slower rate of repolarization in the late phase of AP in a failing
compared with a nonfailing myocyte, which was also found in an
experimental study on human
myocardium.50 The ionic currents and
the [Ca2+]i transients
during the AP are shown in Figures 7
and 8
(nonfailing, dashed line; failing,
solid line). At 4 mmol/L
[K+]o and 140 mmol/L
[K+]i, the resting
membrane potential in this model was only slightly different in both
cell groups (nonfailing, -89.7 mV; failing, -85.6 mV). A greater
discrepancy in resting membrane potential between both cell groups was
prevented by IK1. Although the current
density of IK1 was reduced in a failing
compared with a nonfailing myocyte, the increase of
IK1 in these cells when the resting
potential becomes more positive limits the depolarization of the cell
membrane in a failing myocyte (Figure 7
, IK1).
|
After depolarization of the cell membrane by a suprathreshold stimulus,
INa depolarized the membrane to an
overshoot potential of +50 mV and inactivated immediately
(not shown). Subsequently, ICa,
Ito, IKs, and
IKr were activated, and
INaK increased. The fast activation of
ICa (5 ms) was followed by a rapid
incomplete inactivation to 12% of its peak value (Figure 7
).
Repolarization was initiated by the activation of
Ito. In both cell groups,
Ito activated and
inactivated rapidly (Figure 7
). Thereafter,
IKr and, subsequently,
IKs were completely activated and
accelerated the repolarization, which was completed by the opening of
IK1 channels (Figure 7
). When these
repolarizing currents increased, ICa
deactivated completely. During the plateau and repolarization
phase of AP, INaK counteracted the
depolarization of the cell membrane (Figure 8
).
The total current of the background currents,
ICa,b and
INa,b, during an AP was slightly higher in
a nonfailing myocyte (Figure 8
), so that the alterations in APD in
heart failure may even be underestimated.
In this model, INaCa was a repolarizing
current during most of the AP plateau in a failing myocyte (Figure 7
).
During the late plateau and repolarization phase,
INaCa carried an inward current in its
forward mode and extruded Ca2+ ions out of the
myocyte. By this means, INaCa becomes a
depolarizing current. Therefore, it slows down the rate of membrane
repolarization during the late phase of membrane repolarization,
especially in a failing myocyte, because of its greater size and the
slowed decay of the
[Ca2+]i transient. In
this myocyte, the final repolarization phase was also prolonged because
of the decrease of IK1 (0.68 versus 0.85
pA/pF in a nonfailing myocyte) and of
INaK.
The [Ca2+]i transient
during the AP was markedly different in both cell groups (Figure 8
). As
a result of the higher Ca2+ content in the SR,
the maximum of the Ca2+ transient was higher in a
nonfailing than in a failing myocyte (nonfailing, 1100 nmol/L; failing,
569 nmol/L). The faster inactivation of ICa
in the nonfailing myocyte was caused by enhanced
Ca2+-dependent inactivation of this current and
led, together with higher Ito and
INaK, to a reduction of the plateau phase
of the AP in this myocyte compared with a failing myocyte (nonfailing,
+19.0 mV; failing, +29.2 mV).
In conclusion, these simulations of APs in both groups demonstrate that the prolongation of the AP in a failing myocyte is mainly due to a prolonged late repolarization phase caused by an enhanced activity of the Na+-Ca2+ exchanger and the slowed diastolic decay of the [Ca2+]i transient. The reduction of IK1 and INaK in heart failure additionally contribute to the difference in the late repolarization phase between nonfailing and failing myocytes.
Simulated APs Resemble Those Recorded in Human Ventricular
Myocytes
APs in human ventricular myocytes of nonfailing and
failing hearts measured in different laboratories show a great
variability in duration and shape. Despite using comparable isolation
procedures and recording APs under maintained conditions, a
significant variability remains. APs measured in our laboratory (M.
Lindner, unpublished data) vary more distinctly in failing than in
nonfailing myocytes. Figure 9
shows
measured APs that represent the observed spectrum. It is
obvious that simulated APs (Figure 7
) were generally similar to the
measured APs in nonfailing (Figure 9A
) and failing (Figures 9B
and 9C
)
myocytes. However, a group of recorded APs in failing myocytes
(Figure 9D
) characterized by a pronounced prolonged plateau phase
showed significant differences to the simulation. Possible underlying
factors will be discussed later.
|
Simulated and Experimental APD Restitution Curves Are
Similar
In the human heart, similar to other mammalian hearts, increasing
the pacing rate or shortening of the coupling interval of a premature
beat leads to shortening of the APD.51,52 The
reconstruction of this physiological phenomenon by
this model serves a very important purpose, ie, validation. Therefore,
APD restitution was simulated according to the experimental protocol of
Morgan et al.51 For this purpose, paired stimuli
were used to elicit a second AP (AP2) at variable times after the
initiation of the first (AP1). Before each simulation with a different
time interval, 10 APs were elicited at a frequency of 1 Hz to obtain a
steady state in [Ca2+]i
transients. For clarity, only APs at the following extrastimulus
intervals are shown: 300, 400, 500, 600, 700, and 800 ms (Figure 10A
). APD restitution curves are
depicted in Figure 10B
.
|
APD90 of the second AP obtained in simulations
(Figure 10B
, circle) and in the experiment (Figure 10B
, square) are
plotted as function of extrastimulus interval. The similarity of both
curves substantiates the validity of this model.
The Effect of Ito on the APD in Human
Myocardium Is Small
4-Aminopyridine is known to prolong the AP. From
this result, it has been postulated that reduction of
Ito may prolong the AP in cardiac
myocytes.13,53,54 However, there are additional
effects of 4-aminopyridine on other currents,
especially on ICa23 and
IK.55 With our model,
we can investigate the possible contribution of
Ito to the APD in human
ventricular myocytes. To assess the effect of
Ito on APD, we simulated the APs in both
cell groups under conditions of various degrees of
Ito inhibition (25%, 50%, 75%, and
100%). As described above, the simulations were preceded by 10
stimulations to obtain steady-state conditions. The simulated APs shown
in Figure 11
demonstrate that
inhibition of Ito does not significantly
prolong the AP in a nonfailing (Figure 11A
) or in a failing (Figure 11B
) myocyte.
|
IKr and IKs
Control Repolarization in Human Myocardium
Despite their relative small current densities,
IKr and IKs
largely control repolarization of the AP in human
ventricular myocytes. This effect of
IKr and IKs on
APD in guinea pig ventricular myocytes has already been
demonstrated in a previous computer simulation
study.56 Inhibition of
IKr, the main mechanism of class III
antiarrhythmic agents, has also been shown to prolong the AP in in vivo
mapping studies.5759
Carlsson et al60 have found a pronounced prolongation of the AP in nonfailing human ventricular muscles after inhibition of IKr by 10-6 mol/L H 234/09 (almokalant). At this concentration, almokalant significantly blocks only IKr.61
We attempted to imitate this effect of IKr
on APD in human myocardium by varying
gmax of IKr to 75%,
50%, 25%, and 0% of its original value. To obtain a steady state of
the [Ca2+]i transient, 20
action potentials were elicited. Figure 12A
shows the prolongation of the AP in
a nonfailing cell by inhibition of IKr to
various degrees (left). As in the experimental
study,60 increased inhibition of
IKr resulted in a progressive prolongation
of AP. At 100% inhibition of IKr,
APD90 was lengthened from 374.0 to 689.4 ms,
which is in the range measured by Carlsson at
al.60 This APD prolongation was, however, larger
than that found in single human myocytes after 100% inhibition of
IKr by Li et al.21
This discrepancy may be partially due to the different experimental
conditions. In contrast to our simulations, the intracellular
Ca2+ was buffered by using 5 mmol/L EGTA,
significantly influencing ICa and, thereby,
the AP. Inhibition of IKr also prolonged AP
in a failing myocyte (Figure 12B
, left). In contrast to a nonfailing
myocyte, 50% inhibition of IKr resulted in
an incomplete repolarization of the cell membrane in a failing myocyte
at 1.0 Hz (Figure 12B
, left; 50%). At 75% inhibition of
IKr, even an EAD developed after 3
stimulations. Therefore, a failing myocyte is more sensitive than a
nonfailing myocyte to IKr inhibition.
Simulations with various degrees of inhibition of
IKs have indicated that this current also
has a significant impact on APD in both cell groups (Figure 12A
and 12B
, right). However, inhibition of IKr had
an even greater effect. In a nonfailing myocyte, 100% inhibition of
IKs prolonged APD90
from 374.0 to 526.1 ms. In a failing myocyte, incomplete repolarization
occurred at 100% inhibition of IKs.
|
Complete Inhibition of IKr Induces
Development of Recurrent EADs in Failing Myocytes
The previous simulations reveal the critical role of
IKr in repolarization and, thereby, in the
electric stability of the cell membrane in a failing myocyte.
Therefore, inhibition of IKr may facilitate
the formation of EADs in failing myocytes. At 75% inhibition of
IKr, we can observe an EAD after 3
stimulations. To investigate whether there are recurrent EADs in a
failing myocyte without preconditioning stimulations, simulation of the
action potential in a failing myocytes was performed while assuming
complete inhibition of IKr. The computed
AP, [Ca2+]i transient,
and ICa and
INaCa are shown in Figure 13
. It is obvious that 100% inhibition
of IKr leads to recurrent EADs in a failing
myocyte. IKr inhibition prolonged the time
when the membrane potential was at
-30 mV. This allowed for
sufficient time for reactivation of ICa and
for generation of EADs. During the decay phase of EADs,
INaCa transiently becomes a depolarizing
current. However, the magnitude of INaCa
(-0.05 pA/pF) was much smaller than that of
ICa (-0.5 pA/pF). Therefore, it can be
concluded that EADs are mainly carried by
ICa in our model.
|
The Likelihood of Premature APs Is Enhanced in a Failing
Myocyte
Premature APs can be triggered by DADs, which are caused by a
spontaneous Ca2+ release from the
SR.62,63 Since INaCa
as a possible underlying current is increased in failing myocytes, it
can be expected that premature APs occur more frequently in these
myocytes than in nonfailing cells. However, there is evidence that the
Ca2+ content of SR is decreased in failing
myocytes, which would lead to a smaller Ca2+
increase after spontaneous Ca2+ release from the
SR and, thereby, to a reduced driving force for the depolarizing
INaCa in these cells.
Therefore, it remains unclear whether increased
INaCa in failing myocytes is indeed
combined with a higher occurrence of DADs. Additionally, it should
pointed out that DADs are not, per se, arrhythmogenic. One could rather
imagine that the generation of DADs would result in reduced
excitability of the myocyte by affecting the availability of
Na+ channels. The generation of DADs exerts a
solely proarrhythmogenic effect if the depolarization reaches the
threshold to open Na+ channels and trigger a
premature AP. Consequently, we investigated whether the combined
electrophysiological alterations in heart
failure would enhance the likelihood of premature APs. For this
purpose, a spontaneous Ca2+ release from the SR
was simulated in both cell groups. As Luo and
Rudy64 have shown, the recovery from the slow
inactivation of Na+ channels, named factor j in
their model, determines the recovery of the excitability after the AP.
To investigate the influence of INaCa on
the generation of premature APs separately, the
Na+ channels should be completely recovered from
their slow inactivation at the start of the spontaneous
Ca2+ release from the SR. Therefore, a
spontaneous Ca2+ release from SR was assumed to
occur at least 250 ms after 90% repolarization of the last AP in both
cell groups. After this diastolic time interval, the factor
j=1 (eg, the availability of Na+ channels was
100%) in both cell groups. We assumed an equal
Ca2+-independent mechanism of the spontaneous
Ca2+ release from the SR in both cell groups.
Simulations of spontaneous Ca2+ release from the
SR were preceded by a train of stimulations at 2.0 Hz for elevating the
Ca2+ content of the SR. After 11 stimulations,
there were differences in Ca2+ homeostasis
between both cell groups (Figures 14
and 15
). Before spontaneous
Ca2+ release occurred, diastolic
[Ca2+]i was higher in a
failing myocyte (275 nmol/L) than in a nonfailing myocyte (218 nmol/L).
[Ca2+]NSR was increased
from 2.9 to 3.4 mmol/L in a nonfailing myocyte and from 1.2 to
1.5 mmol/L in a failing myocyte. As expected, the postulated
spontaneous Ca2+ release from the SR resulted in
a greater increase of
[Ca2+]i in a nonfailing
myocyte (1394 nmol/L) than in a failing myocyte (713 nmol/L).
|
|
As a result, depolarizing peak INaCa was
greater in a nonfailing than in a failing myocyte (-1.35 versus -1.0
pA/pF, respectively), although the activity of the
Na+-Ca2+ exchanger was elevated in the
failing myocyte. However, a premature AP was generated only in a
failing myocyte (Figure 15
).
| Discussion |
|---|
|
|
|---|
The influence of IKr and IKs on APD may be one reason for the wide range of measured APDs in different publications (between 233 ms17 and 650 ms13 in single myocytes from nonfailing hearts). Yue et al65 have demonstrated that the expression of IK in cells isolated from the canine heart is very dependent on the isolation technique.
Among other factors, different expressions of
IKr and IKs in
single human myocytes, possibly due to different isolation procedures,
could be a reason for this divergence of APD. However, the AP simulated
in a nonfailing myocyte (Figure 7
) in our model very closely resembles
the AP measured in single cells by our work group (Figure 9A
) and by
Peeters et al.39 When the monophasic AP technique
was used in in vivo studies,51,52 the observed
shape and duration of AP in human hearts were very similar to our
simulations.
In studies of various animal models of heart failure or
hypertrophy, a reduction of Ito
has been found, and this has been assumed to be an important factor
causing AP prolongation in heart failure.54,66,67
In human ventricular myocytes, inhibition of Ito
has been found to prolong AP.13 Our simulations of
different degrees of inhibition of Ito
(Figure 11
) suggest, however, that inhibition of
Ito does not prolong AP in nonfailing or
failing myocytes in human hearts. A reason for this discrepancy could
be that 4-aminopyridine, which was used in the
experimental study,13 also blocked
IKs and IKr,
which would lengthen the AP. Considering this problem in experimental
conditions, we conclude from the simulations of our model that the
influence of Ito on APD is negligible in
human myocardium. Of course, this model cannot prove that
Ito does not alter APD, but it strongly
suggests that reduction of the current density of
Ito found in failing myocytes of human
hearts does not seem to contribute significantly to the APD
prolongation in heart failure. This hypothesis should be tested
experimentally using a highly specific blocker of
Ito in the future. In a human atrial AP
model, it has been demonstrated that the effect of
Ito on the AP is largely dependent on the
magnitude of
IK.68
Therefore, the distinctly different influence of Ito on APD in human ventricular myocytes compared with other cell types and species may be caused mainly by the specific kinetics and magnitude of IKr and IKs found in human ventricular myocytes. In myocytes, where IK is found to be small, Ito may significantly determine the repolarization phase of the AP.69
Prolongation of the AP in human ventricular myocytes of
failing hearts has been well
established.13,22,24,26 Most authors have found
the APD to range between 400 and 1260 ms. In most of these studies,
intracellular Ca2+ was buffered using EGTA in the
pipette solution. Therefore, the influence of
INaCa on the prolongation of the AP can be
only slight in these studies. Our simulations suggest that an APD of
>600 ms can be explained only by assuming a significant reduction of
IKr or IKs
(Figure 12
). In those studies in which APD was very long, the authors
could indeed detect only a small IKr and no
IKs.13,24 As in
nonfailing myocytes, the variability in shape and duration of APs in
failing myocytes measured in our laboratory and in others could
possibly be explained by a variable expression of
IKr and IKs
(Figure 9B
to 9D). Further studies are necessary to show whether
alterations of IKr and
IKs in failing myocytes reflect real
current changes in heart failure or whether they are caused by the
isolation procedure.
Conclusions From the Simulated APs for Arrhythmogenesis in
Heart Failure
From the results shown in Figures 13
, 14
, and 15
, we conclude that
in heart failure one important mechanism for triggered
arrhythmias could be DADs. In our model, DADs were initiated by
a postulated spontaneous Ca2+ release from the
SR. The resulting [Ca2+]i
increase depolarized the cell membrane through
INaCa in both cell groups. Therefore, as in
animal myocytes, this indicates that INaCa
may also significantly contribute to the generation of DADs in human
myocytes.
Although the activity of the Na+-Ca2+
exchanger is enhanced in failing myocytes,
INaCa is slightly larger in nonfailing than
in failing myocytes, since the
[Ca2+]i increase is much
higher in this cell. Nevertheless, a premature AP can be triggered only
in a failing myocyte as the repolarizing ionic currents,
IK1 and INaK,
are reduced in this cell. This indicates that a reduction of
repolarizing currents (IK1 and
INaK) rather than an increase of the
depolarizing current (INaCa) seems to be
responsible for the enhanced likelihood of triggered APs in failing
myocytes. In our model, the increase of the
Na+-Ca2+ exchanger activity in a failing
myocyte can only partially compensate the smaller
[Ca2+]i increase as a
driving force after spontaneous Ca2+ release from
the SR. It should be pointed out that the conclusion of these
simulations is limited by the assumption that the spontaneous
Ca2+ release from the SR is self-initiated and
equal in both cell groups. This limitation is necessary because our
understanding of the mechanisms involved in the spontaneous
Ca2+ release from the SR is incomplete. At
present, the mechanism of the spontaneous
Ca2+ release from the SR is thought to be a
Ca2+ overload of the
cell.70,71 Since the Ca2+
content of the SR increases faster in a nonfailing than in a failing
myocyte at 2.0 Hz (Figures 14
and 15
), the spontaneous
Ca2+ release from the SR after pacing burst and
resulting DADs is expected to occur earlier and more frequently in a
nonfailing than in a failing myocyte, assuming that spontaneous
Ca2+ release occurs if the
Ca2+ content of the SR reaches a threshold level.
This is, however, in contrast to experimental animal studies in which
DADs and triggered APs were observed more frequently in failing or
hypertrophied animal myocytes.72,73 The
development of this model is inadequate to resolve this discrepancy. It
cannot predict the occurrence of spontaneous Ca2+
release from the SR in both cell groups. Nevertheless, it may help to
elucidate whether there are differences in the induction of
DAD-triggered APs between both cell groups. Indeed, the simulations
clearly show that spontaneous Ca2+ release leads
to a triggered AP only in a failing myocyte. From these triggered APs,
triggered arrhythmias may arise.
Even if we assume a higher incidence of spontaneous Ca2+ release from the SR in nonfailing myocytes, the higher incidence of resulting DADs would not result in a higher incidence of triggered arrhythmias than in failing myocytes.
The conclusion about the role of INaCa in DADs and triggered APs does not mean that the Ca2+-dependent nonspecific cation channel has no role in the arrhythmogenesis in heart failure. In animal studies, there is evidence for its contribution in generating DADs.74,75 Luo and Rudy76 concluded from the results of their simulations that the contribution of Ins(Ca) and INaCa to the induction of DADs depends on the level of Ca2+ overload. However, at present, the existence of a nonspecific cation channel in human ventricular myocardium is unknown.
EADs are triggered during the plateau phase of an AP and are thought to
be caused by reactivation of the
ICa.9,10 The membrane
potential has to remain at voltages positive to -35 mV until the
L-type Ca2+ channels are able to recover from
their inactivation and can open again. Detailed models have been
developed addressing this issue. Nordin and
Ming77 showed that current-induced EADs in guinea
pig ventricular myocytes are mainly due to the L-type
Ca2+ channel window current. Zeng and
Rudy78 came to the same conclusion in their model
simulating the effect of cesium, Bay K 8644, and isoproterenol on the
AP. In various preparations, specific block of
IKr has been found to result in EADs in
nonfailing animal myocytes. However, EADs are not generated by
inhibition of IKr block in a nonfailing
myocyte in this model (Figure 12A
, left). Even if the
gmax of IKr and
IKs is changed simultaneously,
corresponding to the approach of Zeng et al56 to
generate EADs in their model, no EADs can be generated in a nonfailing
myocyte (not shown). In contrast to this, 75% inhibition of
IKr can lead to an EAD in a failing myocyte
(Figure 12B
, left; 75%). When the inhibition of
IKr is 100%, even recurrent EADs develop
in this myocyte (Figure 13
).
As already demonstrated in previous models,77,78
reactivated ICa is also the
underling inward current of these EADs. In conclusion, our results
indicate that EADs are difficult to induce in human compared with
animal myocytes. They can be generated only in failing myocytes after
blocking IKr by at least 75% (Figure 12B
, left, and Figure 13
). This discrepancy in EAD formations between animal
models and the present model is supported by experimental data.
Vermeulen et al73 have observed that EADs occur
only in papillary muscles of rabbit hearts but never in human papillary
muscles. Further studies are required to assess the role of EADs in
arrhythmias in human ventricular myocytes.
Besides triggered APs, reentry mechanisms may also contribute to the increased incidence of tachyarrhythmias in heart failure.79 Among many promoting factors, dispersion of refractoriness or wide variations in the duration of APs observed in hypertrophied myocardium80 can evoke reentry arrhythmias.81 Our model can also contribute to the investigation of this type of arrhythmia in heart failure by identifying the ionic currents that are important for the APD in human ventricular myocytes. The simulations demonstrate that IKs has an impact on AP in the human heart. Regional differences of IKs reported in canine left ventricle82 could partially explain the known heterogeneity of the AP in human left ventricle.83 This may also hold true to an increased extent in heart failure. In addition, the increase of INaCa and the alterations of [Ca2+]i handling may also not be uniform in heart failure, thereby increasing the inhomogeneity of the AP across the heart wall. Another factor determining dispersion of APs along the myocardial wall could be the passive electrical properties of the myocardium. Keung et al84 have demonstrated that these are different in normal and hypertrophied rat myocardium. Further studies are necessary to determine whether it also holds true in the human heart.
Limitations of the Model
A variety of models have been developed previously on the basis of
the results of animal studies.31,56,8588 Since
major differences exist in the characteristics of ionic currents
between human and animal myocytes, conclusions drawn from these models
cannot easily be extrapolated to human heart cells. However, although
the present model has the advantage of being based partially on
human data, it also has several limitations.
Significant uncertainty remains concerning the magnitude of INaCa. At present, voltage-clamp data of this current in human ventricular myocytes are not available. Comparison of INaCa incorporated in the model with the measured data in the human atrium suggests that the magnitude of the simulated INaCa has been well estimated. Nevertheless, it should be pointed out that some results have to be interpreted with caution because of their dependence on INaCa. However, the simulations clarify that an increase of INaCa could play an important role in the arrhythmogenesis in heart failure and that its quantification in human ventricular myocytes is desirable.
To simulate [Ca2+]i transients, the approach of the LR model is used. Although major components of intracellular Ca2+ homeostasis are included in this model, this approach is only an approximation of the complex nature of the intracellular Ca2+ homeostasis, since some important features, such as the CICR from the SR or the mechanism of Ca2+ buffering, and their potential changes in heart failure are simplified. This is mainly due to our incomplete understanding of the exact mechanisms involved in these phenomena. Nevertheless, the simulated [Ca2+]i transients in both cell groups agree largely with experimental observations and provide an independent test of how well our model describes [Ca2+]i homeostasis.
Another assumption of the model that has not been investigated is that IKr and IKs are unaltered in heart failure. In addition, information about IKr dependence on [K+]o and IKs dependence on [Ca2+]i is not available at present.
Therefore, it should be stressed that further development of this model is needed for simulating alterations of the APs under various pathophysiological conditions, such as myocardial ischemia, as performed by Shaw and Rudy.89 Nevertheless, the conclusions from the simulations presented here, and also their limitations, highlight several important areas that deserve future experimental studies.
| Selected Abbreviations and Acronyms |
|---|
|
| Appendix 1 |
|---|
|
|
|---|
![]() |
![]() |
For V
-40 mV
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Slow Inward Current: ICa
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Outward Current
Transient Outward Current: Ito
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Delayed Rectifier Current
Slowly Activating Current: IKs
![]() |
![]() |
![]() |
![]() |
![]() |
Rapidly Activating Current: IKr
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Inward Rectifier Current: IK1
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
is the inactivation gate of
IK1, and EK1 is the
equilibrium potential for IK1.
Background Currents
Ca2+ Background Current:
ICa,b
![]() |
![]() |
![]() |
Ca,b is
gmax for ICa,b, and
ECa,b is the equilibrium potential for
ICa,b.
Na+ Background Current:
INa,b
![]() |
![]() |
![]() |
Na,b is
gmax for INa,b, and
ENa,b is the equilibrium potential for
INa,b.
Pump and Exchanger
Na+-K+ Pump:
INaK
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
is the
[Na+]o-dependence factor of
INaK.
Na+-Ca2+ Exchanger Current:
INaCa
![]() |
![]() |
![]() |
![]() |
![]() |
is the position of the energy barrier controlling
voltage dependence of INaCa.
Ca2+ Homeostasis
CICR of JSR
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Spontaneous Ca2+ Release of JSR
![]() |
![]() |
![]() |
![]() |
Ca2+ Uptake and Leakage of NSR:
Iup and Ileak
![]() |
![]() |
![]() |
![]() |
![]() |
Translocation of Ca2+ From NSR to JSR:
Itr
![]() |
![]() |
where Itr is the SR Ca2+ translocation current.
Ca2+ Buffers in the Myoplasm: Troponin (TRPN) and
Calmodulin (CMDN)
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Ca2+ Buffer in JSR: Calsequestrin (CSQN)
![]() |
![]() |
![]() |
| Acknowledgments |
|---|
Received January 5, 1998; accepted April 6, 1998.
| References |
|---|
|
|
|---|
2.
Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL, Cain
ME. Reentrant and focal mechanisms underlying ventricular
tachycardia in the human heart. Circulation. 1992;86:18721887.
3. de Bakker JMT, Coronel R, Tasseron S. Ventricular tachycardia in the infarcted Langendorff perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol. 1990;15:1594607.[Abstract]
4.
de Bakker JMT, Van Capelle FJL, Janse MJ. Reentry as a
cause of ventricular tachycardia in patients
with chronic heart disease:
electrophysiological and anatomic
correlation. Circulation. 1988;77:589606.
5. Gilmour JRF, Heger JJ, Prystowsky EN, Zipes DP. Cellular electrophysiologic abnormalities of diseased human ventricular myocardium. Am J Cardiol. 1983;51:137144.[Medline] [Order article via Infotrieve]
6. Wiederhold KF, Nilius B. Increased sensitivity of ventricular myocardium to intracellular calcium overload in Syrian cardiomyopathic hamster. Biomed Biochim Acta. 1986;45:13331337.[Medline] [Order article via Infotrieve]
7.
Nordin C, Gilat E, Aronson RS. Delayed
afterdepolarizations and triggered activity in ventricular
muscle from rats with streptozotocin-induced diabetes. Circ
Res. 1985;57:2834.
8.
Aronson RS. Afterdepolarizations and triggered
activity in hypertrophied myocardium from rats with renal
hypertension. Circ Res. 1981;48:720727.
9.
January CT, Riddle JM, Salata JJ. A model for early
afterdepolarizations: induction with the Ca2+
channel agonist Bay K 8644. Circ Res. 1988;62:563571.
10.
January CT, Riddle JM. Early afterdepolarizations:
mechanism of induction and block: a role for L-type
Ca2+ current. Circ Res. 1989;64:977990.
11.
Ferrier GL, Saunders JH, Mendez C. A cellular mechanism
for the generation of ventricular arrhythmias by
acetylstrophanthidin. Circ Res. 1973;32:600689.
12. January CT, Fozzard HA. Delayed afterdepolarizations in heart muscle: mechanisms and relevance. Pharmacol Rev. 1988;40:219227.[Medline] [Order article via Infotrieve]
13.
Beuckelmann DJ, Näbauer M, Erdmann E. Alterations
of K+ currents in isolated human
ventricular myocytes from patients with terminal heart
failure. Circ Res. 1993;73:379385.
14.
Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister
JC, Ravens U. Transient outward current in human and rat
ventricular myocytes. Cardiovasc Res. 1993;27:16621669.
15. Mewes T, Ravens U. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol. 1994;26:13071320.[Medline] [Order article via Infotrieve]
16. Beuckelmann DJ, Näbauer M, Erdmann E. Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol. 1991;23:929937.[Medline] [Order article via Infotrieve]
17. Cohen NM, Lederer WJ. Calcium current in single human cardiac myocytes. J Cardiovasc Electrophysiol. 1993;4:422437.[Medline] [Order article via Infotrieve]
18. Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac myocytes. J Cardiovasc Pharmacol. 1995;25:282291.[Medline] [Order article via Infotrieve]
19.
Näbauer M, Beuckelmann DJ, Erdmann E.
Characteristics of transient outward current in human
ventricular myocytes from patients with terminal heart
failure. Circ Res. 1993;73:386394.
20.
Näbauer M, Beuckelmann DJ, Überfuhr P,
Steinbeck G. Regional differences in current density and rate-dependent
properties of the transient outward current in subepicardial and
subendocardial myocytes of human left ventricle.
Circulation. 1996;93:168177.
21.
Li GR, Feng J, Yue L, Carrier M, Nattel S. Evidence for
two components of delayed rectifier K+ current in
human ventricular myocytes. Circ Res. 1996;78:689696.
22.
Koumi S, Backer CL, Arentzen CE. Characterization of
inwardly rectifying K+ channel in human cardiac
myocytes. Alterations in channel behavior in myocytes isolated from
patients with idiopathic dilated cardiomyopathy.
Circulation. 1995;92:164174.
23. Bénitah JP, Bailly P, D'Agrosa MC, Da P, Delgado C, Lorente P. Slow inward current in single myocytes isolated from adult human ventricles. Pflugers Arch. 1992;421:176187.[Medline] [Order article via Infotrieve]
24.
Veldkamp MW, van Ginneken AC, Opthof T, Bouman LN.
Delayed rectifier channels in human ventricular myocytes.
Circulation. 1995;92:34973504.
25.
Sakakibara Y, Furukawa T, Singer DH, Jia H, Backer CL,
Arentzen CE, Wasserstrom JA. Sodium current in isolated human
ventricular myocytes. Am J Physiol. 1993;265:H1301H1309.
26.
Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman
MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in
myocardium from patients with end-stage heart failure.
Circ Res. 1987;61:7076.
27.
Beuckelmann DJ, Näbauer M, Erdmann E.
Intracellular calcium handling in isolated ventricular
myocytes from patients with terminal heart failure.
Circulation. 1992;85:10461055.
28. Reinecke H, Studer R, Vetter R, Holtz J, Drexler H. Cardiac Na+/Ca2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res. 1996;31:4854.[Medline] [Order article via Infotrieve]
29.
Flesch M, Schwinger RHG, Schiffer F, Frank K,
Südkamp M, Kuhn-Regnier F, Arnold G, Böhm M. Evidence for
functional relevance of an enhanced expression of the
Na+-Ca2+ exchanger in
failing human myocardium. Circulation. 1996;94:9921002.
30. Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond). 1952;117:500544.
31.
Luo C-H, Rudy Y. A dynamic model of the cardiac
ventricular action potential, I: simulations of ionic
currents and concentration changes. Circ Res. 1994;74:10711096.
32.
Sipido KR, Callewaert G, Carmeliet E. Inhibition and
rapid recovery of Ca2+ current during
Ca2+ release from sarcoplasmic reticulum in
guinea pig ventricular myocytes. Circ Res.. 1995;76:102109.
33.
De Leon M, Wang Y, Jones L, Perez-Reyes E, Wei X, Wah
Soong T, Snutch TP, Yue DT. Essential
Ca2+-binding motif for
Ca2+-sensitive inactivation of L-type
Ca2+ channels. Science. 1995;270:15021505.
34.
Sanguinetti MC, Jurkiewicz NK. Two components of
cardiac delayed rectifier K+ current:
differential sensitivity to block by class III antiarrhythmic agents.
J Gen Physiol. 1990;96:195215.
35. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT. Mutations in the hmink gene cause long QT syndrome and suppress IKs function. Nat Genet. 1997;17:338340.[Medline] [Order article via Infotrieve]
36.
Those N. Calcium-sensitive delayed rectifier potassium
current in guinea pig ventricular cells. Am J
Physiol. 1990;258:H1200H1207.
37. Sanguinetti MC, Jurkiewicz NK. Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents. Pflugers Arch. 1992;420:180186.[Medline] [Order article via Infotrieve]
38. Sham JSK, Hatem SN, Morad M. Species differences in the activity of the Na+-Ca2+ exchanger in mammalian cardiac myocytes. J Physiol (Lond). 1995;488:3:623631.
39.
Peeters GA, Sanguinetti MC, Eki Y, Konarzewska H,
Renlund DG, Karwande SV, Barry WH. Method for isolation of human
ventricular myocytes from single endocardial and epicardial
biopsies. Am J Physiol. 1995;268:H1757H1764.
40.
Shamraj OI, Grupp IL, Grupp G, Melvin D, Gradoux N,
Kremers W, Lingrel JB, De Pover A. Characterisation of Na/K-ATPase, its
isoforms, and the inotropic response to oubain in isolated failing
human hearts. Cardiovasc Res. 1993;27:22292237.
41.
Holmberg SR, Williams AJ. The calcium-release channel
from cardiac sarcoplasmic reticulum: function in the failing and
acutely ischemic heart. Circ Res. 1989;65:14451449.
42. Schumacher C, Konigs B, Sigmund M, Kohne B, Schondube F, Vob M, Stein B, Weil J, Hanrath P. The ryanodine binding sarcoplasmic reticulum calcium release channel in nonfailing and in failing human myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1995;353:8085.[Medline] [Order article via Infotrieve]
43.
Gwathmey JK, Hajjar RJ. Relation between steady-state
force and intracellular
[Ca2+]i in intact human
myocardium: index of myofibrillar responsiveness to
Ca2+. Circulation.. 1990;82:12661278.
44.
Meyer M, Schillinger W, Pieske B, Holubarsch C,
Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G.
Alterations of sarcoplasmic reticulum proteins in failing human dilated
cardiomyopathy. Circulation. 1995;92:778784.
45. Hilgemann DW, Noble D. Excitation-contraction coupling and extracellular calcium transients in rabbit atrium: reconstruction of basic cellular mechanism. Proc R Soc Lond. 1987;230:163205.[Medline] [Order article via Infotrieve]
46.
Schwinger RH, Böhm M, Schmidt U, Karczewski P,
Bavendiek U, Flesch M, Krause EG, Erdmann E. Unchanged protein levels
of SERCA II and phospholamban but reduced Ca2+
uptake and Ca2+-ATPase activity of cardiac
sarcoplasmic reticulum from dilated cardiomyopathy
patients compared with patients with nonfailing hearts.
Circulation. 1995;92:32203228.
47.
Hasenfuss G, Reinecke H, Studer R, Meyer M,
Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H. Relation
between myocardial function and expression of sarcoplasmic reticulum
Ca2+-ATPase in failing and nonfailing human
myocardium. Circ Res. 1994;75:434442.
48. Beuckelmann DJ, Näbauer M, Krüger C, Erdmann E. Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J. 1995;129:684689.[Medline] [Order article via Infotrieve]
49. Lindner M, Erdmann E, Beuckelmann DJ. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol.. 1998;30:743749.[Medline] [Order article via Infotrieve]
50. Coltart DJ, Meldrum SJ. Hypertrophic cardiomyopathy: an electrophysiological study. Br Med J.. 1970;4:217218.
51.
Morgan JM, Cunningham D, Rowland E. Electrical
restitution in the endocardium of the intact human right ventricle.
Br Heart J. 1992;67:4246.
52. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo: effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest. 1988;82:972979.
53. Berger F, Borchard U, Hafner D, Kammer T, Weis T. Modulation of action potential duration by inhibition of the transient outward current in sheep cardiac Purkinje fibers. Basis Res Cardiol. 1995;90:185191.
54.
Käab S, Nuss HB, Chiamvimonvat N, O'Rourke B,
Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action
potential prolongation in ventricular myocytes from dogs
with pacing-induced heart failure. Circ Res. 1996;78:262273.
55.
Navarro-Polanco RA, Sanchez-Chapula JA.
4-Aminopyridine activates potassium currents by
activation of a muscarinic receptor in feline atrial myocytes.
J Physiol (Lond). 1997;498:3:663678.
56.
Zeng J, Laurita KR, Rosenbaum DS, Rudy Y. Two
components of the delayed rectifier K+ current in
ventricular myocytes of the guinea pig type: theoretical
formulation and their role in repolarization. Circ Res. 1995;77:140152.
57. Huikuri HV, Yli-Mayry S. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle. Pacing Clin Electrophysiol. 1992;15:21032107.[Medline] [Order article via Infotrieve]
58. Hayward RP, Taggart P. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity. Cardiovasc Res. 1986;20:100107.[Medline] [Order article via Infotrieve]
59. Newman D, Dorian P, Feder-Elituv R. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans. Can J Physiol Pharmacol. 1993;71:755760.[Medline] [Order article via Infotrieve]
60. Carlsson L, Abrahamsson C, Almgren O, Lundberg C, Duker G. Prolonged action potential duration and positive inotropy induced by the novel class III antiarrhythmic agent H 234/09 (almokalant) in isolated human ventricular muscle. J Cardiovasc Pharmacol. 1991;18:882887.[Medline] [Order article via Infotrieve]
61.
Wettwer E, Grundke M, Ravens U. Differential effects of
the new class III antiarrhythmic agents almokalant, E-4031 and
D-sotalol, and of quinidine, on delayed rectifier currents in guinea
pig ventricular myocytes. Cardiovasc Res. 1992;26:11451152.
62.
Fedida D, Noble D, Rankin AC, Spindler AJ. The
arrhythmogenic transient inward current Iti and
related contraction in isolated guinea-pig ventricular
myocytes. J Physiol (Lond). 1987;392:523542.
63.
Giles W, Shimoni Y. Comparison of sodium-calcium
exchanger and transient inward currents in single cells from rabbit
ventricle. J Physiol (Lond). 1989;417:465481.
64.
Luo CH, Rudy Y. A model of the ventricular
cardiac action potential. Depolarization, repolarization, and their
interaction. Circ Res. 1991;68:15011526.
65.
Yue L, Feng J, Li GR, Nattel S. Transient outward and
delayed rectifier currents in canine atrium: properties and role of
isolation methods. Am J Physiol. 1996;270:H2157H2168.
66. Thuringer D, Deroubaix E, Coulombe A, Coraboeuf E, Mercadier JJ. Ionic basis of the action potential prolongation in ventricular myocytes from Syrian hamsters with dilated cardiomyopathy. Cardiovasc Res. 1996;31:747757.[Medline] [Order article via Infotrieve]
67.
Cerbai E, Barbieri M, Li Q, Mugelli A. Ionic basis of
action potential prolongation of hypertrophied cardiac myocytes
isolated from hypertensive rats of different ages. Cardiovasc
Res. 1994;28:11801187.
68.
Nygren A, Fiset C, Clark JW, Lindblad DS, Clark RB,
Giles WR. Mathematical model of an adult human atrial cell: the role of
K+ currents in repolarization. Circ
Res. 1998;82:6381.
69. Firek L, Giles WR. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res. 1995;30:3138.[Medline] [Order article via Infotrieve]
70. Stern MD, Capogrossi MC, Lakatta EG. Spontaneous calcium release from the sarcoplasmic reticulum in myocardial cells: mechanisms and consequences. Cell Calcium. 1988;9:247256.[Medline] [Order article via Infotrieve]
71.
Capogrossi MC, Houser SR, Bahinski A, Lakatta EG.
Synchronous occurrence of spontaneous localized calcium release from
the sarcoplasmic reticulum generates action potentials in rat cardiac
ventricular myocytes at normal resting membrane potential.
Circ Res. 1987;61:498503.
72. Aronson RS. Afterdepolarizations and triggered activity in hypertrophied myocardium from rats with renal hypertension. Circ Res. 1981;48:720727.
73. Vermeulen JT, McGuire MA, Opthof T, Coronel R, de Bakker JMT, Klöpping C, Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 1994;28:15471554.[Medline] [Order article via Infotrieve]
74.
Ehara T, Noma A, Ono K. Calcium-activated
non-selective cation channels in ventricular cells isolated
from adult guinea-pig hearts. J Physiol (Lond). 1988;403:117133.
75.
Cannell MB, Lederer WJ. The arrhythmogenic current
Iti in the absence of electrogenic sodium-calcium
exchange in sheep cardiac Purkinje fibres. J Physiol
(Lond). 1986;374:201219.
76.
Luo CH, Rudy Y. A dynamic model of the cardiac
ventricular action potential, II: afterdepolarizations,
triggered activity, and potentiation. Circ Res. 1994;74:10971113.
77.
Nordin C, Ming Z. Computer model of current-induced
early afterdepolarizations in guinea pig ventricular
myocytes. Am J Physiol. 1995;268:H2440H2459.
78. Zeng J, Rudy Y. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J. 1995;68:949964.[Medline] [Order article via Infotrieve]
79. Cranfield PF, Aronson RS. Cardiac Arrhythmias: The Role of Triggered Activity and Other Mechanisms. New York, NY: Futura Publishing Co Inc; 1988.
80.
Keung EC, Aronson RS. Nonuniform
electrophysiological properties and
electrotonic interaction in hypertrophied rat myocardium.
Circ Res. 1981;49:150158.
81. Aronson RS, Ming Z. Cellular mechanisms of arrhythmias in hypertrophied and failing myocardium. Circulation. 1993;87[suppl VII]:VII-76VII-83.
82.
Gintant GA. Regional differences in
IK density in canine left ventricle: role of
IK,s in electrical heterogeneity.
Am J Physiol. 1995;268:H604H613.
83. Drouin E, Charpentier F, Gauthier C, Laurent K Le Marec H. Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol. 1995;26:185192.[Abstract]
84. Keung ECH, Keung CS, Aronson RS. Passive electrical properties of normal and hypertrophied rat myocardium. Am J Physiol. 1982;243:H917H926.
85.
Nordin C. Computer model of membrane current and
intracellular Ca2+ flux in the isolated guinea
pig ventricular myocyte. Am J Physiol. 1993;265:H2117H2136.
86.
DiFrancesco D, Noble D. A model of cardiac electrical
activity incorporating ionic pumps and concentration changes.
Philos Trans R Soc Lond. 1985;307:353398.
87.
Rasmusson RL, Clark JW, Giles WR, Robinson K, Clark RB,
Shibata EF, Campbell DL. A mathematical model of
electrophysiological activity in a bullfrog
atrial cell. Am J Physiol. 1990;259:H370H389.
88.
Lindblad DS, Murphey CR, Clark JW, Giles WR. A model af
the action potential and underlying membrane currents in a rabbit
atrial cell. Am J Physiol. 1996;271:H1666H1696.
89.
Shaw RB, Rudy Y. Electrophysiologic effects of acute
myocardial ischemia: a theoretical study of altered cell
excitability and action potential duration. Cardiovasc Res. 1997;35:256272.
This article has been cited by other articles:
![]() |
M. Potse, A. Vinet, T. Opthof, and R. Coronel Validation of a simple model for the morphology of the T wave in unipolar electrograms Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H792 - H801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fink and D. Noble Markov models for ion channels: versatility versus identifiability and speed Phil Trans R Soc A, June 13, 2009; 367(1896): 2161 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Severi, C. Corsi, and E. Cerbai From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma Phil Trans R Soc A, June 13, 2009; 367(1896): 2203 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Stewart, O. V. Aslanidi, D. Noble, P. J. Noble, M. R. Boyett, and H. Zhang Mathematical models of the electrical action potential of Purkinje fibre cells Phil Trans R Soc A, June 13, 2009; 367(1896): 2225 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, S. Niederer, D. Nordsletten, I. Le Grice, B. Smail, D. Kay, and N. Smith Coupling contraction, excitation, ventricular and coronary blood flow across scale and physics in the heart Phil Trans R Soc A, June 13, 2009; 367(1896): 2311 - 2331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Niederer, H. E. D. J. ter Keurs, and N. P. Smith Modelling and measuring electromechanical coupling in the rat heart Exp Physiol, May 1, 2009; 94(5): 529 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sale, J. Wang, T. J. O'Hara, D. J. Tester, P. Phartiyal, J.-Q. He, Y. Rudy, M. J. Ackerman, and G. A. Robertson Physiological Properties of hERG 1a/1b Heteromeric Currents and a hERG 1b-Specific Mutation Associated With Long-QT Syndrome Circ. Res., September 26, 2008; 103(7): e81 - e95. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rivard, P. Paradis, M. Nemer, and C. Fiset Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization Cardiovasc Res, April 1, 2008; 78(1): 53 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. I. Zhu and C. E. Clancy L-type Ca2+ channel mutations and T-wave alternans: a model study Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3480 - H3489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsaneva-Atanasova, A. Sherman, F. van Goor, and S. S. Stojilkovic Mechanism of Spontaneous and Receptor-Controlled Electrical Activity in Pituitary Somatotrophs: Experiments and Theory J Neurophysiol, July 1, 2007; 98(1): 131 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Qu, V. E. Bondarenko, C. Xie, S. Wang, M. S. Awayda, H. C. Strauss, and M. J. Morales W-7 modulates Kv4.3: pore block and Ca2+-calmodulin inhibition Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2364 - H2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Cherry and F. H. Fenton A tale of two dogs: analyzing two models of canine ventricular electrophysiology Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H43 - H55. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Liu, M. Jiang, M. Zhang, D. Tang, H. F. Clemo, R. S. D. Higgins, and G.-N. Tseng Electrical remodeling in a canine model of ischemic cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H560 - H571. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kurata, H. Matsuda, I. Hisatome, and T. Shibamoto Effects of pacemaker currents on creation and modulation of human ventricular pacemaker: theoretical study with application to biological pacemaker engineering Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H701 - H718. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Flaim, W. R. Giles, and A. D. McCulloch Contributions of sustained INa and IKv43 to transmural heterogeneity of early repolarization and arrhythmogenesis in canine left ventricular myocytes Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2617 - H2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, X. Sun, A. A. Prinz, and H.-S. Wang Effect of simulated Ito on guinea pig and canine ventricular action potential morphology Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H631 - H637. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bo Shim, C. Hun Leem, Y. Abe, and A. Noma A new multi-scale simulation model of the circulation: from cells to system Phil Trans R Soc A, June 15, 2006; 364(1843): 1483 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fink, W. R Giles, and D. Noble Contributions of inwardly rectifying K+ currents to repolarization assessed using mathematical models of human ventricular myocytes Phil Trans R Soc A, May 15, 2006; 364(1842): 1207 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Berecki, J. G. Zegers, Z. A. Bhuiyan, A. O. Verkerk, R. Wilders, and A. C. G. van Ginneken Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique J. Physiol., January 15, 2006; 570(2): 237 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Sipido and D. Eisner Something old, something new: Changing views on the cellular mechanisms of heart failure Cardiovasc Res, November 1, 2005; 68(2): 167 - 174. [Full Text] [PDF] |
||||
![]() |
J. P.P. Smits, M. W. Veldkamp, C. R. Bezzina, Z. A. Bhuiyan, H. Wedekind, E. Schulze-Bahr, and A. A.M. Wilde Substitution of a conserved alanine in the domain IIIS4-S5 linker of the cardiac sodium channel causes long QT syndrome Cardiovasc Res, August 15, 2005; 67(3): 459 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun and H.-S. Wang Role of the transient outward current (Ito) in shaping canine ventricular action potential - a dynamic clamp study J. Physiol., April 15, 2005; 564(2): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, S. V. Pandit, I. Rivolta, O. Berenfeld, E. Ronchetti, A. Dhamoon, C. Napolitano, J. Anumonwo, M. R. di Barletta, S. Gudapakkam, et al. A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene Circ. Res., April 15, 2005; 96(7): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Weiss, G. Seemann, F. B. Sachse, and O. Dössel Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall Europace, January 1, 2005; 7(s2): S105 - S117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellocq, R. Wilders, J.-J. Schott, B. Louerat-Oriou, P. Boisseau, H. Le Marec, D. Escande, and I. Baro A Common Antitussive Drug, Clobutinol, Precipitates the Long QT Syndrome 2 Mol. Pharmacol., November 1, 2004; 66(5): 1093 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yatani, S.-J. Kim, R. K. Kudej, Q. Wang, C. Depre, K. Irie, E. G. Kranias, S. F. Vatner, and D. E. Vatner Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2219 - H2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bellocq, A. C.G. van Ginneken, C. R. Bezzina, M. Alders, D. Escande, M. M.A.M. Mannens, I. Baro, and A. A.M. Wilde Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome Circulation, May 25, 2004; 109(20): 2394 - 2397. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Conrath, R. Wilders, R. Coronel, J. M.T de Bakker, P. Taggart, J. R de Groot, and T. Opthof Intercellular coupling through gap junctions masks M cells in the human heart Cardiovasc Res, May 1, 2004; 62(2): 407 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Wang, Y. Zhang, H. Gao, S. Nattel, and Z. Wang Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-{alpha}: ROLE OF REACTIVE OXYGEN SPECIES AS A MEDIATOR J. Biol. Chem., April 2, 2004; 279(14): 13289 - 13292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. KLEBER and Y. RUDY Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias Physiol Rev, April 1, 2004; 84(2): 431 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. W. J. ten Tusscher, D. Noble, P. J. Noble, and A. V. Panfilov A model for human ventricular tissue Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1573 - H1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Janse Electrophysiological changes in heart failure and their relationship to arrhythmogenesis Cardiovasc Res, February 1, 2004; 61(2): 208 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Weber, V. Piacentino III, S. R. Houser, and D. M. Bers Dynamic Regulation of Sodium/Calcium Exchange Function in Human Heart Failure Circulation, November 4, 2003; 108(18): 2224 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Derksen, H. V.M. van Rijen, R. Wilders, S. Tasseron, R. N.W. Hauer, W. L.C. Rutten, and J. M.T. de Bakker Tissue Discontinuities Affect Conduction Velocity Restitution: A Mechanism by Which Structural Barriers May Promote Wave Break Circulation, August 19, 2003; 108(7): 882 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Lange, F. Er, N. Gassanov, and U. C. Hoppe Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion Cardiovasc Res, August 1, 2003; 59(2): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Bezzina, A. O. Verkerk, A. Busjahn, A. Jeron, J. Erdmann, T. T. Koopmann, Z. A. Bhuiyan, R. Wilders, M. M.A.M. Mannens, H. L. Tan, et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization Cardiovasc Res, July 1, 2003; 59(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schillinger, J. W Fiolet, K. Schlotthauer, and G. Hasenfuss Relevance of Na+-Ca2+ exchange in heart failure Cardiovasc Res, March 15, 2003; 57(4): 921 - 933. [Full Text] [PDF] |
||||
![]() |
R. Sah, R. J Ramirez, G. Y Oudit, D. Gidrewicz, M. G Trivieri, C. Zobel, and P. H Backx Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (Ito) J. Physiol., January 1, 2003; 546(1): 5 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cabo and P. A. Boyden Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H372 - H384. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, L. Zhang, G. Schram, and S. Nattel Properties of potassium currents in Purkinje cells of failing human hearts Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2495 - H2503. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kurata, I. Hisatome, S. Imanishi, and T. Shibamoto Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2074 - H2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zobel, Z. Kassiri, T.-T. T. Nguyen, Y. Meng, and P. H. Backx Prevention of Hypertrophy by Overexpression of Kv4.2 in Cultured Neonatal Cardiomyocytes Circulation, October 29, 2002; 106(18): 2385 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, J. Temple, R. Zhang, I. Dzhura, W. Zhang, R. Trimble, D. M. Roden, R. Passier, E. N. Olson, R. J. Colbran, et al. Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy Circulation, September 3, 2002; 106(10): 1288 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-R. Li, C.-P. Lau, A. Ducharme, J.-C. Tardif, and S. Nattel Transmural action potential and ionic current remodeling in ventricles of failing canine hearts Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1031 - H1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov A computationally efficient electrophysiological model of human ventricular cells Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lacroix, P. Gluais, C. Marquie, C. D'Hoinne, M. Adamantidis, and M. Bastide Repolarization abnormalities and their arrhythmogenic consequences in porcine tachycardia-induced cardiomyopathy Cardiovasc Res, April 1, 2002; 54(1): 42 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Sipido, P. G.A Volders, M. A Vos, and F. Verdonck Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res, March 1, 2002; 53(4): 782 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sah, R. J. Ramirez, and P. H. Backx Modulation of Ca2+ Release in Cardiac Myocytes by Changes in Repolarization Rate: Role of Phase-1 Action Potential Repolarization in Excitation-Contraction Coupling Circ. Res., February 8, 2002; 90(2): 165 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Puglisi and D. M. Bers LabHEART: an interactive computer model of rabbit ventricular myocyte ion channels and Ca transport Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2049 - C2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Han, D. Chartier, D. Li, and S. Nattel Ionic Remodeling of Cardiac Purkinje Cells by Congestive Heart Failure Circulation, October 23, 2001; 104(17): 2095 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Sipido Local Ca2+ Release in Heart Failure : Timing Is Important Circ. Res., November 24, 2000; 87(11): 966 - 968. [Full Text] [PDF] |
||||
![]() |
K. R. Sipido, P. G. A. Volders, S. H. M. de Groot, F. Verdonck, F. Van de Werf, H. J. J. Wellens, and M. A. Vos Enhanced Ca2+ Release and Na/Ca Exchange Activity in Hypertrophied Canine Ventricular Myocytes : Potential Link Between Contractile Adaptation and Arrhythmogenesis Circulation, October 24, 2000; 102(17): 2137 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Trouve, F. Carre, I. Belikova, C. Leclercq, T. Dakhli, L. Soufir, I. Coquard, J. Ramirez-Gil, and D. Charlemagne Na+-K+-ATPase alpha 2-isoform expression in guinea pig hearts during transition from compensation to decompensation Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1972 - H1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Jongsma and R. Wilders Gap Junctions in Cardiovascular Disease Circ. Res., June 23, 2000; 86(12): 1193 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Walker, F. A. Crawford Jr, and F. G. Spinale MYOCYTE CONTRACTILE DYSFUNCTION WITH HYPERTROPHY AND FAILURE: RELEVANCE TO CARDIAC SURGERY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 388 - 400. [Full Text] [PDF] |
||||
![]() |
E. Cerbai, A. Crucitti, L. Sartiani, P. De Paoli, R. Pino, M. L. Rodriguez, G. Gensini, and A. Mugelli Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes Cardiovasc Res, January 14, 2000; 45(2): 388 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. A. Volders, K. R. Sipido, M. A. Vos, R. L. H. M. G. Spatjens, J. D. M. Leunissen, E. Carmeliet, and H. J. J. Wellens Downregulation of Delayed Rectifier K+ Currents in Dogs With Chronic Complete Atrioventricular Block and Acquired Torsades de Pointes Circulation, December 14, 1999; 100(24): 2455 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov A computationally efficient electrophysiological model of human ventricular cells Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sah, R. J. Ramirez, and P. H. Backx Modulation of Ca2+ Release in Cardiac Myocytes by Changes in Repolarization Rate: Role of Phase-1 Action Potential Repolarization in Excitation-Contraction Coupling Circ. Res., February 8, 2002; 90(2): 165 - 173. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |